Services | ABNewswire

Webify IT Solutions Enhances Offerings with Full Stack Web Development Services for Business Growth

Webify IT Solutions, a technology and electronic advertising firm based in India, has expanded its services portfolio to include total stack web development, reflecting a wider shift among businesses wanting more integrated electronic solutions. The update brings development capabilities alongside … Continue reading →

Brian Ferdinand New York Focus Introduces EverForward’s Market Discipline Framework for Finance Leaders

Brian Ferdinand, Portfolio Manager & Trader at EverForward, is introducing EverForward’s market discipline framework for New York finance and business audiences, highlighting the importance of structured execution, defined risk, and decision quality in high-pressure environments. The Brian Ferdinand New York … Continue reading →

Top Reasons Burnaby Homeowners Are Scheduling Air Duct Cleaning with Modern PURAIR®

Rising awareness of indoor air quality, energy efficiency, and home health is driving more Burnaby homeowners to schedule professional air duct cleaning. Modern PURAIR® Burnaby is seeing increased demand as residents prioritize cleaner air and better HVAC performance. Burnaby, BC … Continue reading →

Graves’ Ophthalmopathy Market Forecast Analysis 2034: Clinical Trial, Pipeline, FDA Approvals and companies by DelveInsight

Graves’ Ophthalmopathy Market Graves Ophthalmopathy companies Include Novartis, Harbour BioMed, Viridian Therapeutics, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Sling Therapeutics, ValenzaBio, Argenx, HanAll Biopharma, Immunovant Sciences, Novartis, Viridian Therapeutics And Many Others The Graves’ Ophthalmopathy (Thyroid Eye Disease) market was valued … Continue reading →

Cutaneous Squamous Cell Carcinoma Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline landscape. It covers the Cutaneous Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

Dry Eye Disease Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Dry Eye Disease Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Dry Eye Disease pipeline landscape. It covers the Dry Eye Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Plaque Psoriasis Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Plaque Psoriasis Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Plaque Psoriasis pipeline landscape. It covers the Plaque Psoriasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Autosomal Dominant Polycystic Kidney Disease Clinical Trial Pipeline Expands as 13+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Autosomal Dominant Polycystic Kidney Disease Pipeline Insight 2026” report provides comprehensive insights about 13+ companies and 14+ pipeline drugs in the Autosomal Dominant Polycystic Kidney Disease pipeline landscape. It covers the Autosomal Dominant Polycystic Kidney Disease Pipeline drug profiles, … Continue reading →

Tenosynovial Giant Cell Tumors Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Tenosynovial Giant Cell Tumors Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Tenosynovial Giant Cell Tumors pipeline landscape. It covers the Tenosynovial Giant Cell Tumors pipeline drug profiles, including clinical and nonclinical … Continue reading →

Myasthenia Gravis Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight

DelveInsight’s, “Myasthenia Gravis Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Myasthenia Gravis pipeline landscape. It covers the Myasthenia Gravis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Friday - May 01, 2026

Category Archives: Services